Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.

There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

[1]  J. Messenger,et al.  Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, JAMA.

[2]  F. Burzotta,et al.  Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  S. Price,et al.  Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support , 2020, Intensive Care Medicine.

[4]  F. Pappalardo,et al.  Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization. , 2019, International journal of cardiology.

[5]  J. Spertus,et al.  The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support , 2019, Circulation.

[6]  Armando Pérez de Prado,et al.  Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of Interventional Cardiology Working Group Endorsed by Spanish and Portuguese Interventional Cardiology Societies. , 2019, International journal of cardiology.

[7]  Arthur S Slutsky,et al.  Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review. , 2019, JAMA.

[8]  A. Combes,et al.  Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence. , 2019, Current opinion in critical care.

[9]  J. Ornato,et al.  SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  G. MacLaren,et al.  Autopsy and clinical discrepancies in patients undergoing extracorporeal membrane oxygenation: a case series. , 2019, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  S. Blankenberg,et al.  Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis , 2019, Circulation.

[12]  R. Didomenico,et al.  Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers , 2019, Journal of interventional cardiology.

[13]  A. Kirtane,et al.  Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.

[14]  W. O’Neill,et al.  Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment–Elevation Myocardial Infarction: A Pilot Study Using the Impella CP , 2019, Circulation.

[15]  H. Thiele,et al.  Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial , 2019, Circulation.

[16]  A. Combes,et al.  Contrast-enhanced Doppler echography to assess position of the distal leg perfusion line in patients on venoarterial extracorporeal membrane oxygenation: A preliminary study. , 2018, Artificial organs.

[17]  E. Bennett-Guerrero,et al.  Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members , 2018, Anesthesia and analgesia.

[18]  P. Leprince,et al.  Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation , 2018, Annals of Intensive Care.

[19]  S. Blankenberg,et al.  Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock. , 2018, JACC. Heart failure.

[20]  Naoki Shimizu,et al.  2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary. , 2018, Resuscitation.

[21]  M. Ragosta,et al.  Outcomes of patients with cardiogenic shock treated with TandemHeart® percutaneous ventricular assist device: Importance of support indication and definitive therapies as determinants of prognosis , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  P. Demondion,et al.  Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched study , 2018, Intensive Care Medicine.

[23]  F. Fedele,et al.  Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application , 2018, Cardiovascular Drugs and Therapy.

[24]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[25]  J. Amour,et al.  Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study , 2018, Intensive Care Medicine.

[26]  W. O’Neill,et al.  Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device , 2018, American heart journal.

[27]  J. Bartek,et al.  Incidence, Outcome, and Predictors of Intracranial Hemorrhage in Adult Patients on Extracorporeal Membrane Oxygenation: A Systematic and Narrative Review , 2018, Front. Neurol..

[28]  A. Mebazaa,et al.  Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[29]  R. Karas,et al.  Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[30]  X. Hou,et al.  Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation , 2018, Annals of Intensive Care.

[31]  R. Bellomo,et al.  Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients , 2018, Intensive Care Medicine.

[32]  A. Mebazaa,et al.  Management of cardiogenic shock complicating myocardial infarction , 2018, Intensive Care Medicine.

[33]  W. O’Neill,et al.  Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis , 2018, Circulation. Cardiovascular interventions.

[34]  D. Westermann,et al.  Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry , 2018, Clinical Research in Cardiology.

[35]  A. Scandroglio,et al.  Full percutaneous biventricular support with two Impella pumps: the Bi‐Pella approach , 2018, ESC heart failure.

[36]  M. Slepian,et al.  Peripheral VA-ECMO with direct biventricular decompression for refractory cardiogenic shock , 2018, Perfusion.

[37]  R. V. van Geuns,et al.  Design and principle of operation of the HeartMate PHP (percutaneous heart pump). , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[38]  P. Demondion,et al.  Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation , 2018, European heart journal. Acute cardiovascular care.

[39]  H. Thiele,et al.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. , 2018, The Cochrane database of systematic reviews.

[40]  G. Grasselli,et al.  Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study , 2018, Annals of Intensive Care.

[41]  H. Thiele,et al.  Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.

[42]  J. Cowger,et al.  Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. , 2017, ASAIO journal.

[43]  D. Ramzy,et al.  Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock , 2017, Journal of the American Heart Association.

[44]  L. Camporota,et al.  Severe Respiratory Failure, Extracorporeal Membrane Oxygenation, and Intracranial Hemorrhage* , 2017, Critical care medicine.

[45]  A. Lichtenberg,et al.  Four-year experience of providing mobile extracorporeal life support to out-of-center patients within a suprainstitutional network-Outcome of 160 consecutively treated patients. , 2017, Resuscitation.

[46]  W. Banya,et al.  Should we abandon the APTT for monitoring unfractionated heparin? , 2017, Thrombosis research.

[47]  R. Mehran,et al.  Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters , 2017, JAMA cardiology.

[48]  C. Schwebel,et al.  Argatroban for an alternative anticoagulant in HIT during ECMO , 2017, Journal of Intensive Care.

[49]  J. Gutsche,et al.  Anticoagulation and Transfusion Therapy in Patients Requiring Extracorporeal Membrane Oxygenation. , 2017, Journal of cardiothoracic and vascular anesthesia.

[50]  S. Blankenberg,et al.  Concomitant implantation of Impella® on top of veno‐arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock , 2017, European journal of heart failure.

[51]  M. Seyfarth,et al.  Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock: Meta-Analysis. , 2016, Journal of the American College of Cardiology.

[52]  R. Thiagarajan,et al.  In-Hospital Neurologic Complications in Adult Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry , 2016, Critical care medicine.

[53]  B. D. de Mol,et al.  Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.

[54]  K. Selleng,et al.  Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients , 2016, Thrombosis and Haemostasis.

[55]  H. Hirose,et al.  The Impact of Vascular Complications on Survival of Patients on Venoarterial Extracorporeal Membrane Oxygenation. , 2016, The Annals of thoracic surgery.

[56]  V. Aggarwal,et al.  Current status of percutaneous right ventricular assist devices: First‐in‐man use of a novel dual lumen cannula , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[57]  P. Leprince,et al.  The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock , 2016, Intensive Care Medicine.

[58]  D. Burkhoff,et al.  Hemodynamics of Mechanical Circulatory Support. , 2015, Journal of the American College of Cardiology.

[59]  F. Burzotta,et al.  Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group. , 2015, International journal of cardiology.

[60]  Joshua N. Baker,et al.  Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[61]  D. Mancini,et al.  Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  J. Goldstein,et al.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation , 2015, Journal of cardiac failure.

[63]  J. Haerting,et al.  Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. , 2015, The Cochrane database of systematic reviews.

[64]  Deepak L. Bhatt,et al.  Percutaneous circulatory assist devices for high-risk coronary intervention. , 2015, JACC. Cardiovascular interventions.

[65]  P. Leprince,et al.  Intra-Aortic Balloon Pump Effects on Macrocirculation and Microcirculation in Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation* , 2014, Critical care medicine.

[66]  D. Brodie,et al.  Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. , 2014, Journal of the American College of Cardiology.

[67]  T. Atsumi,et al.  Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. , 2014, Resuscitation.

[68]  I. Palacios,et al.  Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. , 2014, American heart journal.

[69]  R. Cheng,et al.  Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. , 2014, The Annals of thoracic surgery.

[70]  W. O’Neill,et al.  The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry , 2013, Journal of interventional cardiology.

[71]  R. Karas,et al.  Mechanically Unloading the Left Ventricle Before Coronary Reperfusion Reduces Left Ventricular Wall Stress and Myocardial Infarct Size , 2013, Circulation.

[72]  P. Leprince,et al.  Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review , 2013, Critical Care.

[73]  A. Pavie,et al.  Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  R. Stables,et al.  Long-Term Mortality Data From the Balloon Pump–Assisted Coronary Intervention Study (BCIS-1): A Randomized, Controlled Trial of Elective Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention , 2012, Circulation.

[75]  N. Parakh.  Intraaortic balloon support for myocardial infarction with cardiogenic shock , 2012 .

[76]  James O. Mudd,et al.  The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[77]  P. Leprince,et al.  Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[78]  R. D. De Silva,et al.  Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique. , 2012, Heart, lung & circulation.

[79]  Omeed Saghafi.  Intra-aortic Balloon Counterpulsation and Infarct Size in Patients with Acute Anterior Myocardial Infarction without Shock: The CRISP AMI Randomized Trial , 2012 .

[80]  R. Bartlett,et al.  Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era , 2012, Intensive Care Medicine.

[81]  A. Pavie,et al.  Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock , 2011, Intensive Care Medicine.

[82]  A. Moritz,et al.  Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[83]  B. Levy,et al.  Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study* , 2011, Critical care medicine.

[84]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[85]  I. Seong,et al.  Usefulness of mitral annular systolic velocity in the detection of left ventricular systolic dysfunction: comparison with three dimensional echocardiographic data. , 2010, Journal of cardiovascular ultrasound.

[86]  Shing‐Jong Lin,et al.  Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure , 2010, Intensive Care Medicine.

[87]  D. Wagner,et al.  Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. , 2009, Journal of the American College of Cardiology.

[88]  N. Chi,et al.  Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis , 2008, The Lancet.

[89]  Pascal Leprince,et al.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.

[90]  Peter Kleine,et al.  Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. , 2008, The Journal of thoracic and cardiovascular surgery.

[91]  B. Cholley,et al.  Echocardiography in the intensive care unit: from evolution to revolution? , 2008, Intensive Care Medicine.

[92]  N. Chi,et al.  Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.

[93]  H. Ross,et al.  Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. , 2005, The American journal of cardiology.

[94]  S. Yasuda,et al.  Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. , 2005, European heart journal.

[95]  H. Suga,et al.  Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. , 2005, American journal of physiology. Heart and circulatory physiology.

[96]  S. Chu,et al.  Risk Factor Screening Scale to Optimize Treatment for Potential Heart Transplant Candidates under Extracorporeal Membrane Oxygenation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[97]  A. Combes,et al.  Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients , 2004, Intensive Care Medicine.

[98]  A. Chao,et al.  Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. , 2003, Journal of the American College of Cardiology.

[99]  N. Smedira,et al.  Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. , 2001, The Journal of thoracic and cardiovascular surgery.

[100]  S. Bolling,et al.  Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. , 1999, Circulation.

[101]  A. Nogami,et al.  Right ventricular infarction with cardiogenic shock treated with percutaneous cardiopulmonary support: a case report. , 1999, Japanese circulation journal.

[102]  J. J. Griffin,et al.  A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa , 1997 .

[103]  J. J. Griffin,et al.  A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. , 1997, Journal of the American College of Cardiology.

[104]  N. Kapur,et al.  Cardiogenic Shock in the Setting of Acute Myocardial Infarction. , 2020, Methodist DeBakey cardiovascular journal.

[105]  A. Alaiti,et al.  Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock , 2019, ASAIO journal.

[106]  P. Kolh,et al.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[107]  D. Stub,et al.  Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). , 2015, Resuscitation.

[108]  R. Hetzer,et al.  Myocardial recovery during mechanical circulatory support: weaning and explantation criteria , 2015, Heart, lung and vessels.

[109]  D. Fernández de Velasco Pérez.  [Dabigatran versus warfarin in patients with mechanical heart valves]. , 2014, Revista clinica espanola.

[110]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[111]  W. O’Neill,et al.  Real‐world use of the Impella 2.5 circulatory support system in complex high‐risk percutaneous coronary intervention: The USpella Registry , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[112]  C. Schlensak,et al.  Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS) , 2011, Intensive Care Medicine.

[113]  A. Pavie,et al.  Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. , 2009, The Journal of thoracic and cardiovascular surgery.

[114]  S. Trzeciak.  Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest , 2008 .

[115]  B. Kiaii,et al.  Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.

[116]  C. Tribble,et al.  When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. , 2001, The Annals of thoracic surgery.

[117]  S. Yusuf,et al.  Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. , 2001, Journal of the American College of Cardiology.